Company No: 11743749 (England and Wales)

Contents

• Company Information
• Balance Sheet
• Notes to the Financial Statements

DIRECTORS	Mr. A. McClellan (Appointed 20 June 2025)
	Mr. M. Woods

REGISTERED OFFICE	Building 81 Greenham Business Park
	Newbury
	RG19 6HW
	United Kingdom

COMPANY NUMBER

11743749 (England and Wales)

ACCOUNTANT	Verallo
	Century House
	Wargrave Road
	Henley-on-Thames
	Oxfordshire
	United Kingdom
	RG9 2LT

	Note	2024		2023
		£		£
Fixed assets
Investments	3	426,057		426,057
		426,057		426,057
Current assets
Debtors	4	72,294		70,284
Cash at bank and in hand		3,731		6,351
		76,025		76,635
Creditors: amounts falling due within one year	5	( 1,895)		( 1,894)
Net current assets		74,130		74,741
Total assets less current liabilities		500,187		500,798
Net assets		500,187		500,798
Capital and reserves
Called-up share capital	6	100,000		100,000
Capital redemption reserve		400,000		400,000
Profit and loss account		187		798
Total shareholders' funds		500,187		500,798

For the financial year ending 31 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Osteotec Holdings Limited (registered number: 11743749) were approved and authorised for issue by the Board of Directors on 23 September 2025. They were signed on its behalf by:

Mr. M. Woods Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Osteotec Holdings Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Building 81 Greenham Business Park, Newbury, RG19 6HW, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Group accounts exemption

Group accounts exemption s399
The Company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the Company as an individual entity and not about its group.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

2. Employees

	2024		2023
	Number		Number
Monthly average number of persons employed by the Company during the year, including directors	0		0

3. Fixed asset investments

Investments in subsidiaries

	2024
	£
Cost
At 01 January 2024	426,057
At 31 December 2024	426,057
Carrying value at 31 December 2024	426,057
Carrying value at 31 December 2023	426,057

Investments in shares

Name of entity	Registered office	Class of shares	Ownership 31.12.2024
Osteotec Limited	United Kingdom	Ordinary	100.00%
Osteotech Ltd	United Kingdom	Ordinary	100.00%
Osteotec Europe Ltd	United Kingdom	Ordinary	100.00%

The capital and reserves and the profit of the subsidiary undertakings was as follows:

	Capital and reserves at 2024	Profit for the year ended 2024
	£	£
Osteotec Limited	843,364	661,704
Osteotech Ltd	1	0
Osteotec Europe Ltd	1	0

4. Debtors

	2024		2023
	£		£
Trade debtors	( 1)		( 1)
Amounts owed by Group undertakings	72,144		70,144
Prepayments	142		141
VAT recoverable	9		0
	72,294		70,284

5. Creditors: amounts falling due within one year

	2024		2023
	£		£
Accruals	1,895		1,894

6. Called-up share capital

	2024		2023
	£		£
Allotted, called-up and fully-paid
6,000,000 Ordinary A shares of £ 0.01 each	60,000		60,000
2,000,000 Ordinary B shares of £ 0.01 each	20,000		20,000
2,000,000 Ordinary C shares of £ 0.01 each	20,000		20,000
	100,000		100,000

7. Related party transactions

The company is exempt under FRS 102 s33.1A from disclosing any transaction with wholly owned Group companies.

8. Ultimate controlling party

The ultimate controlling party is Mr. M. Woods by virtue of his majority shareholding in the company.